Logo
Lidocaine 1% 2mL Ampoules 10 Ampoules

Lidocaine 1% 2mL Ampoules 10 Ampoules

Generic

Prescription medicine
  • UK Licensed prescription Only medicine (POM) under MHRA oversight (specific product licence number depends on the manufacturer and brand supplied)
  • Manufactured in compliance with Good Manufacturing Practice (GMP) for medicinal products
Local anaesthetic injection

Description

Lidocaine 1% 2mL Ampoules is a prescription-only local anaesthetic injection containing lidocaine hydrochloride 10 mg/mL (20 mg in each 2 mL ampoule). It is supplied as 10 clear glass ampoules of sterile solution for intramuscular (IM), subcutaneous (SC), epidural, caudal, intravenous (IV) injection and IV infusion, to be used by healthcare professionals. Lidocaine injection is indicated for local or regional anaesthesia and for numbing an area of the body to reduce pain and discomfort associated with invasive medical procedures such as needle punctures, minor surgical procedures and other interventions requiring short-acting local anaesthesia.

Bnefits

  • Provides rapid-onset local anaesthesia to numb targeted areas of the body
  • Short-acting local anaesthetic suitable for a wide range of minor procedures
  • 1% (10 mg/mL) strength allows flexible dosing to achieve effective anaesthesia while minimising systemic exposure when used appropriately
  • Supplied in small 2 mL ampoules, convenient for procedures requiring modest volumes of local anaesthetic
  • Can be used for local infiltration, nerve blocks, epidural and caudal anaesthesia, and as an adjunct in certain IV infusions when clinically indicated
  • Well-established safety and efficacy profile with extensive clinical experience
  • Generic formulation aligned with standard pharmacopoeial specifications for lidocaine hydrochloride injection

Indications

  • Local and regional anaesthesia by infiltration, nerve block, epidural or caudal injection for surgical, obstetric and diagnostic procedures, as detailed in the relevant Summary of Product Characteristics (SmPC) for the chosen brand
  • Relief of pain associated with minor surgical or diagnostic procedures, including needle punctures and minor skin procedures, under appropriate medical supervision
  • Adjunctive use in certain intravenous infusion protocols where lidocaine is indicated, in accordance with specialist guidance and product-specific information
  • Use by trained healthcare professionals in hospital, clinic, dental and approved aesthetic practice settings

Composition

  • Active ingredient: Lidocaine hydrochloride 10 mg/mL (1% w/v); each 2 mL ampoule contains 20 mg lidocaine hydrochloride
  • Excipients (typical for 1% lidocaine injection): sodium chloride, sodium hydroxide and/or hydrochloric acid for pH adjustment, and water for injections

Formulation

  • Sterile, clear, colourless aqueous solution for injection/infusion
  • Concentration: 10 mg/mL (1% w/v) lidocaine hydrochloride
  • Presentation: 2 mL clear glass ampoules
  • Pharmaceutical form: solution for injection and infusion for parenteral use by healthcare professionals only

Packaging

  • Carton containing 10 x 2 mL glass ampoules of lidocaine 1% solution for injection
  • Each ampoule labelled with drug name, strength, volume, batch number and expiry date
  • Outer carton printed with product name, concentration, route of administration, storage conditions and regulatory information

Usage

  • For use only by suitably trained and qualified healthcare professionals familiar with local anaesthetic agents, their indications, dosing, contraindications and management of potential complications.
  • Dose, route and technique (e.g. local infiltration, peripheral nerve block, epidural, caudal, IV injection or infusion) must be selected according to the specific procedure, patient age, weight, clinical status and the detailed recommendations in the relevant Summary of Product Characteristics (SmPC).
  • Before administration, visually inspect the solution; only clear, colourless solutions free from visible particles should be used and ampoules must be intact.
  • Aspirate carefully before and during injection to avoid inadvertent intravascular administration when not intended.
  • Use the lowest dose that provides effective anaesthesia, taking account of maximum recommended dose limits for lidocaine (which depend on route, with or without vasoconstrictor and patient factors).
  • Continuous monitoring of the patient’s cardiovascular and respiratory status is required during and after administration, with resuscitation equipment and appropriate medicines immediately available.
  • Discard any unused portion of an opened ampoule; the product is for single use only.
  • Do not mix with other medicinal products in the same syringe or infusion unless compatibility has been established by the specific product literature.

Contraindications

  • Hypersensitivity to lidocaine, other amide-type local anaesthetics or any excipient in the formulation
  • Complete heart block not treated by a pacemaker when lidocaine is used systemically
  • Severe shock or hypotension where local anaesthetic administration may pose additional risk, unless potential benefit outweighs risk and specialist supervision is available
  • Intravenous regional anaesthesia (Bier’s block) when using lidocaine preparations containing preservatives or where specifically contraindicated by the chosen brand’s SmPC
  • Epidural or caudal administration in patients with severe hypotension, hypovolaemia, coagulation disorders or infection at the injection site, unless adequately corrected and under expert supervision
  • Any additional contraindications stated in the SmPC for the particular licensed product being used must be followed

Adverse Effects

  • Common dose-related effects of local anaesthetics: dizziness, circumoral numbness, paresthesia, tinnitus, blurred vision, metallic taste and tremor, particularly if plasma levels rise due to inadvertent intravascular injection or overdose
  • Central nervous system toxicity at higher plasma levels including agitation, confusion, muscle twitching, convulsions, and in severe cases respiratory depression or arrest
  • Cardiovascular effects such as hypotension, bradycardia, arrhythmias, conduction disturbances and, in severe toxicity, cardiovascular collapse
  • Local reactions at injection site such as pain, bruising, oedema or, rarely, tissue necrosis if injected intravascularly or intra-arterially by mistake
  • Allergic or hypersensitivity reactions, including rash, pruritus, urticaria, bronchospasm and in rare cases anaphylaxis
  • Neurological complications associated with regional techniques (e.g. nerve injury, prolonged sensory or motor block, epidural or spinal complications), which may relate to technique as well as the medicinal product

Storage Conditions

  • Store according to the instructions on the outer carton and ampoule label, typically below 25°C and protected from light.
  • Do not refrigerate or freeze unless the specific product literature states otherwise.
  • Keep ampoules in the outer carton until use to protect from light and physical damage.
  • Do not use after the expiry date printed on the packaging.
  • Use only clear, particle-free solutions in intact ampoules; discard any ampoule that is cracked, damaged or contains discoloured or particulate solution.
  • Keep out of the sight and reach of children.

Duration

Single or repeated administration during the course of a procedure or short treatment episode, as determined by the clinical indication and professional judgement. The duration of local anaesthetic effect is typically limited to a few hours, with repeat dosing subject to maximum recommended total dose and appropriate monitoring.

Onset

Lidocaine injection usually produces local anaesthesia within a few minutes of administration, depending on the route and site of injection, with effects generally lasting from approximately 30 minutes to several hours.

Browse more Prescription medicine

Top Treatments

Top Cities in the UK